{
    "nctId": "NCT00201851",
    "briefTitle": "Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer",
    "officialTitle": "Phase III Randomized Study of Immediate Versus Luteal Phase Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-positive Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 740,
    "primaryOutcomeMeasure": "Disease-free Survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Open for accrual in Asia only\n* Female age 18-50,\n* premenopausal with regular cycles (\\>25-35 in length)\n* fine-needle aspiration diagnosis\n* Stage II-IIIA hormone receptor positive invasive breast cancer\n* No prior radiation or chemotherapy\n* Must be surgical candidate for bilateral oophorectomy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}